Literature DB >> 16338417

"Wide-open" 1.3 A structure of a multidrug-resistant HIV-1 protease as a drug target.

Philip Martin1, John F Vickrey, Gheorghe Proteasa, Yurytzy L Jimenez, Zdzislaw Wawrzak, Mark A Winters, Thomas C Merigan, Ladislau C Kovari.   

Abstract

This report examines structural changes in a highly mutated, clinical multidrug-resistant HIV-1 protease, and the crystal structure has been solved to 1.3 A resolution in the absence of any inhibitor. This protease variant contains codon mutations at positions 10, 36, 46, 54, 62, 63, 71, 82, 84, and 90 that confer resistance to protease inhibitors. Major differences between the wild-type and the variant include a structural change initiated by the M36V mutation and amplified by additional mutations in the flaps of the protease, resulting in a "wide-open" structure that represents an opening that is 8 A wider than the "open" structure of the wild-type protease. A second structural change is triggered by the L90M mutation that results in reshaping the 23-32 segment. A third key structural change of the protease is due to the mutations from longer to shorter amino acid side chains at positions 82 and 84.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338417     DOI: 10.1016/j.str.2005.11.005

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  51 in total

1.  HIV-1 protease with 20 mutations exhibits extreme resistance to clinical inhibitors through coordinated structural rearrangements.

Authors:  Johnson Agniswamy; Chen-Hsiang Shen; Annie Aniana; Jane M Sayer; John M Louis; Irene T Weber
Journal:  Biochemistry       Date:  2012-03-20       Impact factor: 3.162

2.  Spin labeling and Double Electron-Electron Resonance (DEER) to Deconstruct Conformational Ensembles of HIV Protease.

Authors:  Thomas M Casey; Gail E Fanucci
Journal:  Methods Enzymol       Date:  2015-09-01       Impact factor: 1.600

3.  Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts.

Authors:  Zhanglong Liu; Thomas M Casey; Mandy E Blackburn; Xi Huang; Linh Pham; Ian Mitchelle S de Vera; Jeffrey D Carter; Jamie L Kear-Scott; Angelo M Veloro; Luis Galiano; Gail E Fanucci
Journal:  Phys Chem Chem Phys       Date:  2016-02-17       Impact factor: 3.676

Review 4.  Targeting structural flexibility in HIV-1 protease inhibitor binding.

Authors:  Viktor Hornak; Carlos Simmerling
Journal:  Drug Discov Today       Date:  2006-12-20       Impact factor: 7.851

5.  The open structure of a multi-drug-resistant HIV-1 protease is stabilized by crystal packing contacts.

Authors:  Melinda Layten; Viktor Hornak; Carlos Simmerling
Journal:  J Am Chem Soc       Date:  2006-10-18       Impact factor: 15.419

6.  Atomistic simulations of the HIV-1 protease folding inhibition.

Authors:  Gennady Verkhivker; Guido Tiana; Carlo Camilloni; Davide Provasi; Ricardo A Broglia
Journal:  Biophys J       Date:  2008-03-28       Impact factor: 4.033

7.  Solution structure of HIV-1 protease flaps probed by comparison of molecular dynamics simulation ensembles and EPR experiments.

Authors:  Fangyu Ding; Melinda Layten; Carlos Simmerling
Journal:  J Am Chem Soc       Date:  2008-05-15       Impact factor: 15.419

8.  Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes.

Authors:  Arthur H Robbins; Roxana M Coman; Edith Bracho-Sanchez; Marty A Fernandez; C Taylor Gilliland; Mi Li; Mavis Agbandje-McKenna; Alexander Wlodawer; Ben M Dunn; Robert McKenna
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-02-12

9.  Nine crystal structures determine the substrate envelope of the MDR HIV-1 protease.

Authors:  Zhigang Liu; Yong Wang; Joseph Brunzelle; Iulia A Kovari; Ladislau C Kovari
Journal:  Protein J       Date:  2011-03       Impact factor: 2.371

10.  Drug pressure selected mutations in HIV-1 protease alter flap conformations.

Authors:  Luis Galiano; Fangyu Ding; Angelo M Veloro; Mandy E Blackburn; Carlos Simmerling; Gail E Fanucci
Journal:  J Am Chem Soc       Date:  2009-01-21       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.